Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances

Despite substantial developments in conventional treatments such as surgery, chemotherapy, radiotherapy, endocrine therapy, and molecular‐targeted therapy, breast cancer remains the leading cause of cancer mortality in women. Currently, chimeric antigen receptor (CAR)–redirected immune cell therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikoo, Marzieh, Rudiansyah, Mohammad, Bokov, Dmitry Olegovich, Jainakbaev, Nurlan T., Suksatan, Wanich, Ansari, Mohammad Javed, Thangavelu, Lakshmi, Chupradit, Supat, Zamani, Amir, Adili, Ali, Shomali, Navid, Akbari, Morteza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344815/
https://www.ncbi.nlm.nih.gov/pubmed/35762299
http://dx.doi.org/10.1111/jcmm.17465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344815/
https://www.ncbi.nlm.nih.gov/pubmed/35762299
http://dx.doi.org/10.1111/jcmm.17465

Ejemplares similares